Incannex Healthcare Limited (Nasdaq: IXHL), a clinical stage pharmaceutical development company visits the Nasdaq MarketSite in Times Square. In honor of the occasion, Mr Joel Latham, Managing Director & CEO, rings the Closing Bell.
Further reading
Related news
Cannabis stock Bod Australia (ASX:BDA) has entered the fight against what is known as “long-COVID”. What is ‘long-COVID’? “Long-COVID” ... Read More The post 1 in 10 COVID survivors in Britain still suffer symptoms; ASX cannabis stock Bod wants to help appeared first on Stockhead.
Special Report: The June quarter demonstrated IHL’s ability to execute on a multi-channel development strategy. ... Read More The post A busy Q4 shows how Incannex Healthcare is laying the foundations for its clinically backed global growth strategy appeared first on Stockhead.
One of the few bright spots in ASX Covid news in the past week, amidst the emergence of the Omicron ... Read More The post As Biotron more than doubles on promising COVID results, which other ASX stocks are working on treatments? appeared first on Stockhead.